EMA Assessing If Kidney Injury In COVID-19 Patients Is Linked To Remdesivir

While an EU panel is examining reports of acute kidney injury in some COVID-19 patients taking remdesivir, researchers conducting a UK-based study are preparing to update their systematic benefit-risk analysis of the drug as and when more safety data becomes available.

Vials_Remdesivir
Veklury Was Approved In Record Time In The EU • Source: Shutterstock

More from Drug Safety

More from Pink Sheet